Healthcare Triangle 8-K: Leadership & Compensation Changes
Ticker: HCTI · Form: 8-K · Filed: Feb 1, 2024 · CIK: 1839285
| Field | Detail |
|---|---|
| Company | Healthcare Triangle, Inc. (HCTI) |
| Form Type | 8-K |
| Filed Date | Feb 1, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**Healthcare Triangle filed an 8-K about executive changes and pay, watch for strategic shifts.**
AI Summary
Healthcare Triangle, Inc. filed an 8-K on February 1, 2024, reporting on changes related to the departure or election of directors or certain officers, as well as compensatory arrangements for certain officers. The filing also covers financial statements and exhibits. This matters to investors because changes in leadership and executive compensation can signal shifts in company strategy, financial health, or governance, potentially impacting future stock performance.
Why It Matters
Changes in executive leadership and compensation can directly influence a company's strategic direction and operational efficiency, which are critical factors for stock valuation.
Risk Assessment
Risk Level: medium — Changes in leadership can introduce uncertainty, but the specific details of the changes are not provided in this summary, making the exact impact unclear.
Analyst Insight
Investors should monitor Healthcare Triangle, Inc.'s future filings and press releases for specific details regarding the executive changes and compensation arrangements to assess their potential impact on the company's strategy and financial outlook.
Key Numbers
- February 1, 2024 — Date of Report (Indicates when the reported events occurred and the filing was made.)
- $0.00001 — Par Value per Share (The nominal value of Healthcare Triangle's common stock.)
Key Players & Entities
- Healthcare Triangle, Inc. (company) — registrant filing the 8-K
- February 1, 2024 (date) — date of earliest event reported and filing date
- 001-40903 (null) — Commission File Number
- Delaware (null) — State of incorporation
- HCTI (null) — Trading Symbol on Nasdaq
- $0.00001 (dollar_amount) — par value per share of Common Stock
Forward-Looking Statements
- Healthcare Triangle, Inc. will provide more specific details on the executive changes and compensation in subsequent filings or press releases. (Healthcare Triangle, Inc.) — medium confidence, target: Q1 2024
FAQ
What specific events are reported in this 8-K filing by Healthcare Triangle, Inc.?
The 8-K reports on 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'Financial Statements and Exhibits' as of February 1, 2024.
What is the trading symbol and exchange for Healthcare Triangle, Inc.'s common stock?
Healthcare Triangle, Inc.'s common stock trades under the symbol HCTI on The Nasdaq Stock Market LLC.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 1, 2024.
What is the state of incorporation for Healthcare Triangle, Inc.?
Healthcare Triangle, Inc. is incorporated in Delaware.
What is the par value of Healthcare Triangle, Inc.'s common stock?
The common stock of Healthcare Triangle, Inc. has a par value of $0.00001 per share.
Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-02-01 17:00:13
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar
Filing Documents
- ea192644-8k_health.htm (8-K) — 24KB
- ea192644ex99-1_health.htm (EX-99.1) — 5KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- ex99-1_002.jpg (GRAPHIC) — 7KB
- 0001213900-24-009064.txt ( ) — 223KB
- hcti-20240201.xsd (EX-101.SCH) — 3KB
- hcti-20240201_lab.xml (EX-101.LAB) — 33KB
- hcti-20240201_pre.xml (EX-101.PRE) — 22KB
- ea192644-8k_health_htm.xml (XML) — 4KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 1, 2024, Mr. Lakshmanan Kannappan notified the Board of the Company of his resignation as a member of the Board of the Company, effective immediately. Mr. Kannappan's decision to resign from the Board is solely for personal reasons and time considerations, and is not as a result of any disagreement with the Company relating to the Company's operations, policies, or practices, or otherwise. As there are no disagreements as contemplated by Item 5.02(a) of Form 8-K, the Company is disclosing this information pursuant to Item 5.02(b) of Form 8-K. A copy of their resignation letter is filed with this report as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Resignation Letter, dated as of February 1, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Healthcare Triangle, Inc. Date: February 1, 2024 By: /s/ Thyagarajan Ramachandran Name: Thyagarajan Ramachandran Title: Chief Financial Officer 2